Portfolio News Venatorx Pharmaceuticals

Venatorx Pharmaceuticals Expands Senior Leadership Team

By WebmasterMarch 12, 2024December 12th, 2024No Comments

Venatorx Pharmaceuticals Expands Senior Leadership Team

Key Hires in CMC/Technical Operations, Business Development, and Finance

Previous PostSIRPant Immunotherapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating SIRPant-M in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma
Next PostiView Therapeutics Inc. Announced FDA’s Clearance of IND Application for IVW-1001 Ophthalmic Eyelid Wipe to Treat Signs and Symptoms of Dry Eye Disease